| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |